Accordingly, genetically modified mouse models represent relevant systems to better characterize the role of EGFR in liver fibrosis and in the crosstalk between hepatocytes and macrophages cells that influences HCC development. The gene discussed is EGFR; the disease is hepatocellular carcinoma.